首页> 外文期刊>Einstein (So Paulo) >Prevention of thromboembolic events in patients with atrial fibrillation – new anticoagulants
【24h】

Prevention of thromboembolic events in patients with atrial fibrillation – new anticoagulants

机译:预防房颤患者的血栓栓塞事件–新型抗凝剂

获取原文
获取外文期刊封面目录资料

摘要

ABSTRACTThe authors present alternatives for the treatment of cardiac arrhythmias. Its detection is based on the use of different methods that record the cardiac electrical activity. The treatment involves intervening in the underlying disorder, antiarrhythmic drugs, stimulation and cardiac defibrillation devices, and, less often, surgery. The technological advances in the last two decades have provided greater efficiency in diagnoses and therapy. Atrial fibrilation patients will benefit from a new set of anticoagulant drugs tested in the past three years. The potential advantages include greater safety and efficacy, as well as convenience for not requiring frequent laboratory controls.
机译:摘要作者提出了治疗心律不齐的替代方法。它的检测基于记录心脏电活动的不同方法的使用。治疗包括干预潜在的疾病,抗心律不齐药物,刺激和心脏除颤设备,以及较少的手术。近二十年来的技术进步提供了更高的诊断和治疗效率。心房纤颤患者将受益于过去三年中测试的一组新的抗凝药物。潜在的优势包括更高的安全性和功效,以及无需频繁进行实验室控制的便利性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号